Co-Authors
This is a "connection" page, showing publications co-authored by VIVEK SUBBIAH and SRDAN VERSTOVSEK.
Connection Strength
1.116
-
Clinical development and management of adverse events associated with FGFR inhibitors. Cell Rep Med. 2023 10 17; 4(10):101204.
Score: 0.918
-
Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor. Ann Oncol. 2018 08 01; 29(8):1880-1882.
Score: 0.161
-
Myeloid/lymphoid neoplasms with FGFR1 rearrangement. Leuk Lymphoma. 2018 07; 59(7):1672-1676.
Score: 0.038